Allergan board spurns Valeant's $47B offer

Allergan says its board was unanimous in spurning an unsolicited $47 billion takeover bid from Valeant Pharmaceuticals and William Ackman's Pershing Capital Management hedge fund.

Pershing Capital Management, Valeant Pharmaceuticals, Allergan Inc.

News Well, Cosmetic/Aesthetic, Mergers & Acquisitions, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1lcGurx